PATENT CLAIM ANALYSIS

Application Number: 16234951
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-05
Patent Classification: ["424", "472000"]

Abstract:
The invention relates to tablet comprising granules dispersed in at least one hydrophilic compound or matrix. The granules contain an active agent, at least one amphiphilic compound and at least one lipophilic compound. The tablet may include a gastro-resistant film coating.

Claim (Index 1):
A controlled release oral pharmaceutical composition in the form of a tablet consisting essentially of:\n (1) a tablet core consisting of a mixture of ingredients, said ingredients comprising:\n a) budesonide in an amount to treat intestinal inflammation; \n b) hydroxyalkyl cellulose; \n c) lactose; \n d) colloidal silica; and \n e) microcrystalline cellulose; and \n (2) a gastro-resistant film coating on said tablet core, said coating comprising at least one methacrylic acid polymer or methacrylic acid copolymer.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 98.0
- Lexical Diversity: 1.45161
- Patent Class: 424.0
- Transitional Phrase Type: half
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15369296', '14308279', '14308305', '15646538', '15646330']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7881733714590492
- 35 USC 102 Novelty (BERT): 0.5149505676177414
- Combined Prediction Score: 0.7608510910749184
- Mean Citation Score: 339.281906
- Max Citation Score: 351.14145
- Similarity Product: 316.8785059569955

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test